Innovations in Active Surveillance Management of Early Prostate Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Epidemiology and Prevention".
Deadline for manuscript submissions: 8 August 2026 | Viewed by 895
Special Issue Editor
2. Department of Surgery, University of Cambridge, Cambridge, UK
3. Department of Urology, Cambridge University Hospitals, Cambridge, UK
Interests: prostate cancer; risk stratification; active surveillance; prognostic markers; translational research
Special Issue Information
Dear Colleagues,
Prostate cancer is the most common cancer diagnosed in the West and the second most common male cancer globally. The majority of diagnosed men, however, will live with rather than die from prostate cancer. For many men, treatment may in fact only bring harm without any tangible survival benefit. Active surveillance is a disease management strategy that monitors early prostate cancer with a low probability of ever causing harm in a patient’s natural lifetime. In modern PSA-detected prostate cancer populations, up to a quarter of men diagnosed may be eligible for active surveillance.
Despite its importance as a management option in clinical practice, most academic literature on active surveillance is based on data extrapolated from other treatments or from expert/consensus opinion. In this Special Issue of Cancers, we seek to address this evidence gap by highlighting research that has been based on investigating cohorts of men on surveillance and in whom clinic-pathological features, prediction tools, imaging, or biomarkers have been tested and explored. We particularly welcome articles that look at the natural history of early cancers, methods for risk-adapted surveillance, and tools that may detect progression to a clinically meaningful endpoint. We look forward to receiving your submissions.
Prof. Dr. Vincent J. Gnanapragasam
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prostate cancer
- risk stratification
- active surveillance
- predictive markers
- personalized management
- imaging
- biomarkers
- clinical pathways
- patient outcomes
- standardizing care
- attrition
- cohort studies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
